Pioneer factor Foxa2 enables ligand-dependent activation of type II nuclear receptors FXR and LXRα – Medicine Innovates Share LinkedIn
Medicine Innovates Medicine Innovates: Delivering innovations in medicine to the world for better health and prosperity
